TY - BOOK ID - 61122179 TI - Natural Compounds as New Cancer Treatments PY - 2019 SN - 3039213660 3039213652 PB - MDPI - Multidisciplinary Digital Publishing Institute DB - UniCat KW - microbiota KW - treatment KW - n/a KW - sulforaphane KW - synergy KW - epigenetic KW - natural compound KW - xenohormesis KW - anticancer KW - miR-663 KW - tyrosine kinase inhibitors KW - acetylation KW - epidemiology KW - double-blinded KW - inflammation KW - bladder cancer KW - polypharmacology KW - animal model KW - synbiotics KW - resveratrol KW - royal jelly KW - 5-aza-2’-deoxycytine KW - saponins KW - phenolics KW - cardiovascular disease KW - antioxidant KW - colorectal cancer KW - trypsin inhibitors KW - seeds KW - green tea KW - Gac KW - randomized clinical trial KW - melanoma KW - adverse events KW - extraction KW - microbiome KW - Momordica cochinchinensis KW - freeze dried extract KW - renal cell carcinoma KW - methylation KW - cancer KW - probiotics KW - 5-aza-2'-deoxycytine UR - https://www.unicat.be/uniCat?func=search&query=sysid:61122179 AB - Cancer remains one of the main causes of morbidity and mortality worldwide. Although many pharmacological and clinical advances have been made, there is a constant need for new molecules to improve the overall options for treatment. Natural compounds from animal, microbial, vegetal, or fungal origin represent countless sources of new compounds that can be used as anticancer drugs, provided their activity, bioavailability, and toxicity are adequate. This book aims to compile both original articles and reviews that cover the most recent advances in the use of natural compounds for cancer treatment, and provide new objectives and advice for future research in the field of biological activity of natural compounds. ER -